Median Diagnostics Inc. develops, produces, and sells diagnostic methods and kits for early diagnosis and constant monitoring of infectious diseases outbreak in animals and human. Its products include PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; ELISA for pigs, ruminants, avians, and horses; standard reagents, including AGID, HI, and FA; and antigen/antibody, including antibodies for veterinary diagnostics, and antibodies and antigens for human diagnostics. It also offers mouse and rat pathogens and antibodies test; as well as honey authenticity test kit and VDPro JEV AG ELISA. The company was formerly known as JENO Biotech Inc. and changed its name to Median Diagnostics Inc. in July 2011. Median Diagnostics Inc. was founded in 1999 and is headquartered in Chuncheon-si, South Korea.
Metrics to compare | 233250 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship233250PeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | −4.4x | −0.5x | |
PEG Ratio | 0.00 | −0.09 | 0.00 | |
Price/Book | 0.0x | 2.1x | 2.6x | |
Price / LTM Sales | 0.0x | 18.6x | 3.2x | |
Upside (Analyst Target) | 0.0% | 33.9% | 45.7% | |
Fair Value Upside | Unlock | 3.9% | 8.6% | Unlock |